{
    "id": 27326,
    "fullName": "KRAS A59X",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "KRAS A59X indicates any KRAS missense mutation that results in replacement of the lysine (K) at amino acid 59 by a different amino acid.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 3845,
        "geneSymbol": "KRAS",
        "terms": [
            "KRAS",
            "'C-K-RAS",
            "C-K-RAS",
            "c-Ki-ras",
            "c-Ki-ras2",
            "CFC2",
            "K-Ras",
            "K-Ras 2",
            "K-RAS2A",
            "K-RAS2B",
            "K-RAS4A",
            "K-RAS4B",
            "KI-RAS",
            "KRAS1",
            "KRAS2",
            "NS",
            "NS3",
            "OES",
            "RALD",
            "RASK2"
        ]
    },
    "variant": "A59X",
    "createDate": "12/11/2017",
    "updateDate": "11/12/2019",
    "referenceTranscriptCoordinates": {
        "id": 156968,
        "transcript": "NM_033360",
        "gDna": "chr12:g.25227347_25227349",
        "cDna": "c.175_177",
        "protein": "p.A59",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17100,
            "approvalStatus": "FDA contraindicated",
            "evidenceType": "Actionable",
            "efficacyEvidence": "Erbitux (cetuximab) treatment of colorectal cancer patients with KRAS exon 3, codon 59 mutations is contraindicated (FDA.gov).",
            "molecularProfile": {
                "id": 28753,
                "profileName": "KRAS A59X"
            },
            "therapy": {
                "id": 694,
                "therapyName": "Cetuximab",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15479,
                    "pubMedId": null,
                    "title": "Erbitux (cetuximab) FDA Drug Label",
                    "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125084"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 17111,
            "approvalStatus": "FDA contraindicated",
            "evidenceType": "Actionable",
            "efficacyEvidence": "Vectibix (panitumumab) treatment of colorectal cancer patients with KRAS exon 3, codon 59 mutations is contraindicated (FDA.gov).",
            "molecularProfile": {
                "id": 28753,
                "profileName": "KRAS A59X"
            },
            "therapy": {
                "id": 845,
                "therapyName": "Panitumumab",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15480,
                    "pubMedId": null,
                    "title": "Vectibix (panitumumab) FDA Drug Label",
                    "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125147"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28753,
            "profileName": "KRAS A59X",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 156971,
            "transcript": "XM_006719069",
            "gDna": "chr12:g.25227347_25227349",
            "cDna": "c.175_177",
            "protein": "p.A59",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 156968,
            "transcript": "NM_033360",
            "gDna": "chr12:g.25227347_25227349",
            "cDna": "c.175_177",
            "protein": "p.A59",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 156970,
            "transcript": "XM_011520653",
            "gDna": "chr12:g.25227347_25227349",
            "cDna": "c.175_177",
            "protein": "p.A59",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 156967,
            "transcript": "NM_004985",
            "gDna": "chr12:g.25227347_25227349",
            "cDna": "c.175_177",
            "protein": "p.A59",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 156969,
            "transcript": "XM_017019293",
            "gDna": "chr12:g.25227347_25227349",
            "cDna": "c.175_177",
            "protein": "p.A59",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}